TITLE:
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis

CONDITION:
Anemia

INTERVENTION:
darbepoetin alfa

SUMMARY:

      This study will assess the efficacy and safety of subcutaneous Mircera in the treatment of
      renal anemia in patients with chronic kidney disease who are not on dialysis and not
      receiving epoetin or any other erythropoietic substance. The anticipated time on study
      treatment is 1-2 years and the target sample size is 100-500 individuals.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  adult patients >=18 years of age;

          -  chronic kidney disease;

          -  anemia;

          -  not on dialysis therapy;

          -  not receiving epoetin.

        Exclusion Criteria:

          -  women who are pregnant, breastfeeding or using unreliable birth control methods;

          -  administration of another investigational drug within 4 weeks before screening, or
             during the study period.
      
